Home


  • The world`s largest and fastest growing freeze drying system brand.
  • Tofflon became a public company on the China Shenzhen Stock Exchange on February 1, 2011.
  • 8000 equipments and systems for 2000 pharmaceutical companies in the fields of liquid and lyo injectables, chemical API, bioengineering and pharma packaging, etc.
  • Tofflon has installations more than 40 countries and regions including USA, Canada, Germany, France, Britain, Italy, Spain, Switzerland, Greece, Poland, Turkey, Russia, Belarus, Ukraine, Kazakhstan, Uzbekistan, Egypt, Tunisia, Sudan, The United Arab Emirates, India, Pakistan, Bangladeshi, China, Singapore, Korea, Hong Kong, Taiwan, Indonesia, Malaysia, Thailand, Vietnam, Mexico, Brazil, Peru and Argentina, etc.
  • Five modern pharmaceutical equipments manufacturing bases (250,000㎡) with global competitiveness.
  • International certificates: German TUV ISO9001 / ISO14000 / OHSAS 18001 / European CE / American UL / US FDA 21 CFR Part 11 / European PED / American ASME and Russian Gost-R, etc.
  • Headquarter in Shanghai and Global Operations in USA, Europe, India and Russia.
  • Our technology development concept: Automation, Intelligence, Modularization, Continuous Processing and Systems Integration.
  • Synergy global advanced technologies, Serve dynamic emerging markets.
  • Building global R&D centers and technical centers in China, USA, Germany, Italy and India.
  • Joint Ventures and Technical Partners: Japan Kyowac (Freeze Dryer) / Japan Airex (Barrier Systems) / Japan Top System (Auto Solution Preparation Systems) / USA Praxair (LN2 Refrigeration Freeze Dryer) / Italy AVS (Intelligent Vision Systems), etc.
  • What we study today and tomorrow: drug manufacture science and process equipment manufacture science for smart pharma factory building.
  • Tofflons goal is to grow from China Tofflon to Global Tofflon and from Equipment Supplier to Solution Provider so as to grow up to a total solution provider of pharmaceutical manufacturing systems and engineering for the global pharma and biotech industry.